NGGT Inc.
PrivateLast Round
Series B
Jul 11, 2023
Total Funding Raised
$70M
Company Overview
NGGT Inc. is a biotechnology company that develops gene therapies for the treatment of rare genetic diseases, including retinal, metabolic, and neurodegenerative disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NGGT Inc. Comparables
Compare NGGT Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Capsida Biotherapeutics | 81% | |
| Vivet Therapeutics | 80% | |
| Beacon Therapeutics | 76% | |
NGGT Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 11, 2023 | ||||
| Series A | Apr 15, 2021 | ||||
| Angel | Jul 1, 2020 |
NGGT Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Shanghai Healthcare Capital | Series B |
| YuanBio Venture Capital | Angel, Series A |
| Northern Light Venture Capital | Angel, Series B, Series A |
| 德同资本 | Series B |
| Infinity Group | Series B |
NGGT Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NGGT Inc.'s valuation, stock price, and market status.